title: [Atherosclerotic renal artery disease management update].
abstract: In the case of atherosclerotic renal artery disease, the best conclusive results lie principally not in the degree of the stenosis but rather in the degree the renal parenchymal disease beyond the stenosis itself. These determining factors involve the controlling of the patients blood pressure, the improvement in the renal function and the beneficial results to the cardiovascular system. Besides the indispensable medical treatment, a revascularisation by angioplasty may be indicated. This procedure with or without vascular stent often allows satisfactory angiographic results. A treatment by surgical revascularisation is only recommended in the case of extensive atherosclerotic lesions of the aorta, complex lesions of the latter or an abdominal aortic aneurism. Although the frequency of restenosis of angioplasty with stent remains extremely low, the risk of cholesterol emboli due to the diffuse atherosclerotic lesions of the abdominal aorta, must be considered at the time of each aortic catheterization. The therapeutic approach of atherosclerotic renal artery disease must be dictated by the whole cardiovascular risk factors and by the threat of target organs. The control of the blood pressure and the maintenance of the renal function must be integrated in the decisional algorithm as well as the possible risks in carrying out an eventual revascularisation procedure. Finally, the renal angioplasty should in numerous situations be integrated in the overall assumption of responsibility of the atherosclerotic vascular diseases, and should be part of the medical treatment. Several questions still do exist; at what moment an atherosclerotic renal artery stenosis should and e considered critical, and which procedure should be considered for which patient? The purpose of this review is to propose a decisional tool for individualized treatments in the light of results from randomized and controlled studies.
authors.affiliation: Service de néphrologie et hypertension, centre hospitalier universitaire Vaudois, université de Lausanne, rue du Bugnon, 1011 Lausanne, Suisse. pascal.meier@chuv.ch
authors.forename: Pascal
authors.initials: P
authors.lastname: Meier
authors.forename: Erik
authors.initials: E
authors.lastname: Haesler
authors.forename: Daniel
authors.initials: D
authors.lastname: Teta
authors.forename: Salah Dine
authors.initials: SD
authors.lastname: Qanadli
authors.forename: Michel
authors.initials: M
authors.lastname: Burnier
mesh_terms: D017130:Angioplasty; D050197:Atherosclerosis / Q000628:therapy*; D003663:Decision Trees; D006801:Humans; D012077:Renal Artery